Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |